Iron supplementation significantly elevated the expression of Cox10, the mutations of which are associated with mitochondrial disease, and Bola3 and Isca2, the mutations of which are associated with MMDS and/or oxidative phosphorylation activity33,37,38 (Fig. 7a,c). The gene discussed is BOLA3; the disease is inborn mitochondrial metabolism disorder.